ACADIA PHARMACEUTICALS INC (ACAD) Cash flow
Market cap
$3.7B
P/E ratio
9.5x
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Stock-based compensation | 2 | 2 | 6 | 16 | 40 | 55 | 76 | 82 | 82 | 84 | 64 | 68 | 66 | 67 | 52 |
| Cash from operations | -20 | -22 | -32 | -66 | -122 | -210 | -218 | -167 | -151 | -136 | -126 | -114 | 17 | 158 | 110 |
| Capital expenditures | - | 0 | -1 | -0 | -2 | -2 | -1 | -2 | -1 | -8 | -1 | - | -0 | -1 | -5 |
| Cash from investing | 6 | -26 | -126 | -87 | 148 | -262 | 92 | -71 | -166 | 193 | -71 | 73 | 32 | -31 | -303 |
| Repayments of term debt | 0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | 14 | 98 | 112 | 204 | 15 | 534 | 31 | 307 | 372 | 81 | 18 | 8 | 25 | 7 | 50 |
| Free cash flow | - | - | |||||||||||||
| FCF margin (%) | - | - |